NIH/NATIONAL HEART, LUNG AND BLOOD INSTITUTE NIH RECOVER research identifies potential long COVID disparities NIH-supported studies show variations in symptoms and diagnostic experiences among different racial and ethnic groups Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID, a lay term that captures an array of symptoms and health problems,...
Tag: <span>NIH</span>
Post
Haima Therapeutics licenses synthetic platelet technology from CWRU for hemostatic therapy
Haima Therapeutics has executed an exclusive license agreement with Case Western Reserve University to research, develop, and market artificial platelet technologies to treat patients with various bleeding disorders. The core technologies were developed in the laboratory of Professor Anirban Sen Gupta, a pioneering researcher in platelet-inspired technologies in the Department of Biomedical Engineering at the...
Post
NIH clinical trial of remdesivir to treat COVID-19 begins
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is the National Institute of Allergy and Infectious Diseases (NIAID), part of the National...